Superfluid Dx is a biotechnology company developing novel blood-based early detection.
Superfluid Dx's investors include Index Ventures, Pfizer, DCVC, AAF Management Ltd., Premji Invest.
Superfluid Dx is headquartered in San Diego, United States.
Superfluid Dx is a biotechnology company developing novel blood-based early detection.
Superfluid Dx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Superfluid Dx — Funding & Investors." VCBacked, December 20, 2023, https://www.vcbacked.co/company/superfluid-dx. Accessed August 6, 2026.
VCBacked. (2023). Superfluid Dx — Funding & Investors. Retrieved August 6, 2026, from https://www.vcbacked.co/company/superfluid-dx
{{cite web |title=Superfluid Dx — Funding & Investors |url=https://www.vcbacked.co/company/superfluid-dx |website=VCBacked |access-date=August 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated